Abstract:Background: The incidence of post-stroke depression (PSD) may be higher in patients with cancer-associated ischemic stroke (CAIS). The pathogenesis of PSD is mainly related to the emotional injury of stroke and the inability of neurons to effectively repair. This study aims to explore the clinical significance of serum neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) expression levels in CAIS patients. Methods: Clinical data of 106 patients with CAIS admitted to Jinhua Guangfu Oncology Hospital from January 2012 to December 2022 were retrospectively analyzed. Serum levels of NSE, BDNF and CNTF were measured in all patients after admission. Depression screening was performed by Hamilton Depression Scale-17 (HAMD-17) three months after intravenous thrombolysis. Patients with HAMD-17 score >7 were included in the PSD group (n = 44), and patients with HAMD-17 score ≤7 were included in the non-PSD group (n = 62). The general data and serum levels of NSE, BDNF and CNTF were compared between the two groups. According to HAMD-17 scores, patients in PSD group were further divided into mild depression group (8-16 points), moderate depression group (17-23 points) and severe depression group (≥24 points), and the serum levels of NSE, BDNF and CNTF were compared among the three groups. Pearson's correlation test was used to analyze the correlation between HAMD-17 scores and serum NSE, BDNF and CNTF levels in PSD patients. Logistic regression model was used to determine the influencing factors of PSD in CAIS patients. Receiver operating characteristic (ROC) curve was plotted to analyze the predictive efficacy of serum NSE, BDNF, CNTF and their combination on PSD. Results: Among 106 CAIS patients, the incidence of PSD was 41.51% (44 cases), including 19 patients with mild PSD (43.18%), 14 patients with moderate PSD (31.82%), and 11 patients with severe PSD (25.00%). There were statistically significant differences in negative life events and complications after thrombolytic therapy between PSD and non-PSD patients (p < 0.05). The serum NSE level in PSD group was significantly higher than that in non-PSD group, and the serum BDNF and CNTF levels were notably lower than those in non-PSD group (all p < 0.001). The serum levels of NSE, BDNF and CNTF in patients with different severity of PSD were statistically significant (all p < 0.001). HAMD-17 scores in PSD patients were positively correlated with serum NSE levels (r = 0.676, p < 0.001) and negatively correlated with serum BDNF and CNTF levels (r = -0.661, p < 0.001; r = -0.401, p = 0.007, respectively). By binary logistic regression analysis, the levels of serum NSE, BDNF and CNTF were independent influencing factors for PSD in CAIS patients, among which NSE was a risk factor (odds ratio (OR) >1, p < 0.05), BDNF and CNTF were protective factors (OR <1, p < 0.05). Conclusion: This study reveals for the first time that the levels of serum NSE, BDNF and CNTF are closely related to the occurrence and development of PSD in CAIS patients. In clinical CAIS patients with abnormal changes in the above indicators, in addition to anti-tumor treatment and improvement of neurological deficit symptoms, attention should also be paid to the symptoms of psychological disorders.

Higher serum lipocalin 2 is associated with post-stroke depression at discharge

Higher Serum Lactic Dehydrogenase is Associated with Post-Stroke Depression at Discharge

Low Serum Superoxide Dismutase is Associated with a High Risk of Cognitive Impairment after Mild Acute Ischemic Stroke

Correlation between serum lipocalin-2 and white matter hyperintensities in patients with ischemic stroke

Serum levels of homocysteine at admission are associated with post-stroke depression in acute ischemic stroke

Lower Serum Uric Acid Is Associated With Post-Stroke Depression at Discharge

Relationship Between Serum Neutrophil Gelatinase-Associated Lipocalin Levels and Cognitive Impairment, Anxiety, and Depressive Symptoms in Acute Ischemic Stroke

Predictive Value of Inflammatory Indicators for Post-Stroke Depression in Patients with Ischemic Stroke

Correlation of Lipoprotein-Associated Phospholipase A2 and Cerebral Microbleeds in Patients with Acute Ischaemic Stroke

Lesion Location and Serum Levels of Homocysteine Are Associated with Early-Onset Post-Stroke Depression in Acute Ischemic Stroke.

Serum Levels and Clinical Significance of NSE, BDNF and CNTF in Patients with Cancer-associated Ischemic Stroke Complicated with Post-stroke Depression

The Serum Interleukin-18 is a Potential Marker for Development of Post-Stroke Depression

Elevated Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Post-Stroke Depression with Acute Ischemic Stroke.

Interleukin-10 Level is Associated with Post-Stroke Depression in Acute Ischaemic Stroke Patients

Serum Dickkopf-1 levels and poststroke depression in ischemic stroke patients

Low Serum BDNF May Indicate the Development of PSD in Patients with Acute Ischemic Stroke

Higher Concentration of Adrenocorticotropic Hormone Predicts Post-Stroke Depression

Plasma Soluble Suppression of Tumorigenicity 2 and Depression after Acute Ischemic Stroke

Role of lipocalin 2 in stroke

Clinical Predictor and Circulating Microrna Profile Expression in Patients with Early Onset Post-Stroke Depression

Association between high serum total bilirubin and post-stroke depression.